Evidence map›Paper›PMID 11884615›Full record

ArticleMolecular and cellular biology2002

Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Janiel M Shields, Heena Mehta, Kevin Pruitt, Channing J Der

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. New insights into the regulation of the actin cytoskeleton by tropomyosin.International review of cell and molecular biology · 2010
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Janiel M ShieldsDepartment of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 27599, USA. shieldsj@med.unc.edu
Heena Mehta
Kevin Pruitt
Channing J Der
University of North Carolina at Chapel Hill · US

Funding

BIOLOGICAL ACTIVITY OF RAS ONCOGENESR01CA042978 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1986 to 2017
$5.9M
RHO FAMILY PROTEINS AND MALIGNANT TRANSFORMATIONR01CA063071 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J · 1994 to 2007
$2.0M
FUNCTION OF RAS ONCOGENE PROTEIN RELATED RAB PROTEINSR01CA055008 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J · 1991 to 1995
–
NCI NIH HHS CA42978NCI NIH HHS CA55008NCI NIH HHS CA63071NCI NIH HHS R01 CA042978NCI NIH HHS R01 CA063071
6 · The paper itself

Abstract

We showed previously that activated Ras, but not Raf, causes transformation of RIE-1 epithelial cells, demonstrating the importance of Raf-independent pathways in mediating Ras transformation. To assess the mechanism by which Raf-independent effector signaling pathways contribute to Ras-mediated transformation, we recently utilized representational difference analysis to identify genes expressed in a deregulated fashion by activated Ras but not Raf. One gene identified in these analyses encodes for alpha-tropomyosin. Therefore, we evaluated the mechanism by which Ras causes the downregulation of tropomyosin expression. By using RIE-1 cells that harbor inducible expression of activated H-Ras(12V), we determined that the downregulation of tropomyosin expression correlated with the onset of morphological transformation. We found that the reversal of Ras transformation caused by inhibition of extracellular signal-regulated kinase activation corresponded to a restoration of tropomyosin expression. Inhibition of p38 activity in Raf-expressing RIE-1 cells caused both morphological transformation and loss of tropomyosin expression. Thus, a reduction in tropomyosin expression correlated strictly with morphological transformation of RIE-1 cells. However, forced overexpression of tropomyosin in Ras-transformed cells did not reverse morphological or growth transformation, a finding consistent with the possibility that multiple changes in gene expression contribute to Ras transformation. We also determined that tropomyosin expression was low in two human tumor cell lines, DLD-1 and HT1080, that harbor endogenous mutated alleles of ras, but high in transformation-impaired, derivative cell lines in which the mutant ras allele has been genetically deleted. Finally, treatment with azadeoxycytidine restored tropomyosin expression in Ras-transformed RIE-1, HT1080, and DLD-1 cells, suggesting a role for DNA methylation in downregulating tropomyosin expression.

Indexed as

Down-RegulationSignal TransductionAnimalsBlotting, WesternCell DivisionCell LineCell Transformation, NeoplasticDeoxycytidineDNA MethylationFluorescent Antibody TechniqueHumansMitogen-Activated Protein KinasesOncogene Protein p21(ras)Oncogene Proteins v-rafp38 Mitogen-Activated Protein Kinasesras ProteinsDeoxycytidineMitogen-Activated Protein KinasesOncogene Protein p21(ras)Oncogene Proteins v-rafp38 Mitogen-Activated Protein Kinasesras Proteinsrho GTP-Binding ProteinsRNA, MessengerTropomyosin

Identifiers

PMID11884615
PMCPMC133695
OpenAlexW2136859630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.